Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
This study meets the NIH definition of a clinical trial, but is not a treatment study. Instead, the goal of this study is to investigate how hearing ourselves speak affects the planning and execution of speech movements. The study investigates this topic in both typical speakers and in patients with Deep Brain Stimulation (DBS) implants. The main questions it aims to answer are:
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
General inclusion criteria:
Specific inclusion criteria for children:
* scoring above the 20th percentile on the Peabody Picture Vocabulary Test (PPVT-5), Expressive Vocabulary Test (EVT-3), Goldman-Fristoe Test of Articulation (GFTA-3), and either Test of Early Language Development (TELD-4) or (for children age 8 or older) Clinical Evaluation of Language Fundamentals (CELF-5).
Specific inclusion criteria for DBS patients:
* bilateral electrodes implanted in either the ventral intermediate nucleus of the thalamus (Vim; a target site for patients with essential tremor) or subthalamic nucleus (STN; a target site for patients with Parkinson's disease)
Primary purpose
Allocation
Interventional model
Masking
507 participants in 3 patient groups
Loading...
Central trial contact
Ludo Max
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal